Haemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil.

dc.creatorRibeiro, Guilherme de Sousa
dc.creatorLima, Josilene Borges T
dc.creatorReis, Joice Neves
dc.creatorGouveia, Edilane Lins
dc.creatorCordeiro, Soraia Machado
dc.creatorLôbo, Tatiana Silva
dc.creatorPinheiro, Ricardo M
dc.creatorRibeiro, Cássio Tâmara
dc.creatorNeves, Alan B
dc.creatorSalgado, Kátia M
dc.creatorSilva, Hagamenon R
dc.creatorReis, Mitermayer Galvão dos
dc.creatorKo, Albert Icksang
dc.date2014-04-25T13:44:30Z
dc.date2014-04-25T13:44:30Z
dc.date2007
dc.date.accessioned2023-09-26T20:42:01Z
dc.date.available2023-09-26T20:42:01Z
dc.identifierRIBEIRO, G. S. et al. Haemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil. Vaccine, v. 25, n. 22, p. 4420-4428, 2007.
dc.identifier0264-410X
dc.identifier10.1016/j.vaccine.2007.03.024
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/7539
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8862264
dc.descriptionThe long-term impact of Haemophilus influenzae type b (Hib) conjugate vaccine, introduced throughout Latin America in the late 1990s, has not been evaluated. Active surveillance for H. influenzae meningitis was performed from August 9, 1996 to August 8, 2004 in Metropolitan Salvador, Brazil. Five years after the introduction of Hib conjugate vaccine, Hib meningitis incidence decreased from 2.39 to 0.06 cases per 100,000 population (98%) overall, and from 60.9 to 3.1 cases per 100,000 population (95%) in children <1 year of age. A transient serotype replacement phenomenon was observed associated with a small increase of meningitis due to two H. influenzae type a clonal groups. These findings indicate that Hib immunization campaign has led to the virtual elimination of Hib disease in this region. © 2007 Elsevier Ltd. All rights reserved.
dc.formatapplication/pdf
dc.languageeng
dc.publisherElsevier
dc.rightsopen access
dc.subjectHaemophilus influenzae
dc.subjectVaccine effectiveness
dc.subjectSerotype replacement
dc.subjectVacinas Anti-Haemophilus
dc.subjectHaemophilus influenzae tipo b/imunologia
dc.subjectProgramas de Imunização
dc.subjectMeningite por Haemophilus/epidemiologia
dc.subjectVigilância da População
dc.subjectToxoide Tetânico
dc.subjectVacinas Conjugadas
dc.subjectBrasil/epidemiologia
dc.subjectCriança
dc.subjectPré-Escolar
dc.subjectVacinas Anti-Haemophilus/administração & dosagem
dc.subjectHaemophilus influenzae tipo b/classificação
dc.subjectHumanos
dc.subjectLactente
dc.subjectRecém-Nascido
dc.subjectMeningite por Haemophilus/microbiologia
dc.subjectMeningite por Haemophilus/prevenção & controle
dc.subjectAvaliação de Programas e Projetos de Saúde
dc.subjectToxoide Tetânico/administração & dosagem
dc.subjectVacinas Conjugadas/administração & dosagem
dc.titleHaemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil.
dc.typeArticle


Este ítem pertenece a la siguiente institución